Table 1.
Patient characteristics and disease status at diagnosis and at data analysis.
| Characteristics | N = 375 |
|---|---|
| Age, years; mean ± SD | 74.8 ± 7.1 |
| Comorbidities; n (%)† | 230 (61.7) |
| ECOG performance status, 0-1; n (%)† | 284 (76.9) |
| PSA, ng/mL; mean ± SD | 50.5 ± 135.6 |
| Gleason score at diagnosis; n (%)† | |
| 2–6 | 50 (13.8) |
| 7 | 140 (38.6) |
| 8–10 | 173 (47.7) |
| D'Amico risk classification at diagnosis; n (%)† | |
| Low | 23 (6.4) |
| Intermediate | 97 (27.2) |
| High | 237 (66.4) |
| Extent of disease; n (%) | |
| Bone metastases | 172 (45.9) |
| Lymph node | 89 (23.7) |
| Lung metastases | 22 (5.9) |
| Pain associated with disseminated disease; n (%) | 227 (60.6) |
†Missing data on variable: comorbidities, n = 2; ECOG, n = 6; Gleason score, n = 12; D'Amico risk group classification, n = 18. SD: standard deviation; PCa: prostate cancer; ECOG: Eastern Cooperative Oncology Group; PSA: prostate specific antigen.